You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Immunol., 16 January 2023

Sec. Inflammation

Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1138316

Corrigendum: Increased levels of interleukin-36 in obesity and type 2 diabetes fuels adipose tissue inflammation by inducing its own expression and release by adipocytes and macrophages

  • 1. Metabolic Research Laboratory, Clínica Universidad de Navarra, Pamplona, Spain

  • 2. CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Pamplona, Spain

  • 3. Obesity and Adipobiology Group, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain

  • 4. Department of Endocrinology and Nutrition, Clínica Universidad de Navarra, Pamplona, Spain

  • 5. Department of Microbiology, Clínica Universidad de Navarra, Pamplona, Spain

  • 6. Department of Surgery, Clínica Universidad de Navarra, Pamplona, Spain

  • 7. Department of Anesthesia, Clínica Universidad de Navarra, Pamplona, Spain

Article metrics

View details

1

Citations

951

Views

654

Downloads

In the published article, there was an error in the Funding statement. Instead of “Instituto de Salud Carlos III”, the correct name for the funder is “Spanish Instituto de Salud Carlos III–Subdirección General de Evaluación y Fomento de la investigación–FEDER”. The correct Funding statement appears below.

Statements

Funding

Funded by Spanish Instituto de Salud Carlos III–Subdirección General de Evaluación y Fomento de la investigación–FEDER (project PI19/00785, PI20/00080 and PI20/00927) and CIBEROBN. Funding sources had no role in manuscript writing or the decision to submit it for publication.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

IL-36, inflammation, obesity, adipose tissue, macrophages, fibrosis

Citation

Frühbeck G, Gómez-Ambrosi J, Ramírez B, Mentxaka A, Rodríguez A, Becerril S, Reina G, Valentí V, Moncada R, Silva C and Catalán V (2023) Corrigendum: Increased levels of interleukin-36 in obesity and type 2 diabetes fuels adipose tissue inflammation by inducing its own expression and release by adipocytes and macrophages. Front. Immunol. 14:1138316. doi: 10.3389/fimmu.2023.1138316

Received

05 January 2023

Accepted

06 January 2023

Published

16 January 2023

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

14 - 2023

Updates

Copyright

*Correspondence: Victoria Catalán, ; Gema Frühbeck,

This article was submitted to Inflammation, a section of the journal Frontiers in Immunology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics